Anne Wojcicki's nonprofit, TTAM Research Institute, has received court approval to acquire 23andMe, the genetic testing company she co-founded.

Remember 23andMe.

Stocks closed broadly higher as Wall Street navigates through the uncertainty of a trade war.

23andMe, the popular at-home genetic testing company, has helped millions of people uncover their family roots and health risks through DNA analysis. Experts fear as the company faces financial issues they may sell the data.

Curious about the latest buzz in Houston? We've got the inside scoop on stories that matter this week.

Amid financial struggles and major layoffs, 23andMe customers are questioning the security of their genetic data.

Questions linger about the company’s future and what happens to the DNA data of millions of customers.

All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the genetic-testing company.

Vanner Johnson’s wife, Donna, had purchased the take-home genetic testing kit 23andMe for fun. But when her husband received his family’s 23andMe results in August 2019, he noticed something odd. His 11-year-old son, Tim, wasn’t listed as his biological relative. The couple soon learned that the hospital where Donna had undergone in vitro fertilization (IVF) 12 years earlier had likely mixed up the sperm samples. Vanner wasn’t Tim’s biological dad.